ACuteTox - An In-Vitro Test Strategy for Predicting Human Acute Toxicity
| Knowledge Source Identification | |
|---|---|
| Knowledge source name | ACuteTox - An In-Vitro Test Strategy for Predicting Human Acute Toxicity |
| Abbreviated name | ACuteTox |
| Owner/Developer | European Commission |
| Abbreviated owner | EC |
| Country | Sweden |
| Languages | English |
| URL | http://www.acutetox.eu/ |
| Contact | Dr. Cecilia Clemedson |
| Contact email | info@acutetox.eu |
| Description | The AcuteTox project is now finished. The project lasted from January 1st 2005 to June 30th 2010. The ACuteTox set the very ambitious overall objective of developing an in vitro test strategy sufficiently robust and powerful to completely replace in vivo testing of acute toxicity of chemicals. Anticipated corollary results of this overall objective are decreased testing costs and improved scientific validity of the results. |
| Knowledge Source Category | |
| Category | Research Program/Project/Grant |
| Sub categories | EU Program |
| Knowledge Dissemination and Sharing | |
| Dissemination channel | Website |
| Targeted audience (specified/objective analysis) | Not specified |
| Knowledge Characterization | |
| 3Rs relevance | Replacement |
| Purpose | Toxicological and safety evaluation, Regulatory testing |
| Legislative framework | CLP Regulation (EC) No 1272/2008 |
| Technology/Tools | Alternative test methods (in vitro), Non-testing methods (in silico) |